What to do: If you have an allergy to peanuts do not consume recalled product
Audience: General public
Recall class: Class II
Affected product
Brand
Product
Size
UPC
Codes
Q One Homemade
Blackrice & Honey Hoddeok Mix
400 g
8 801013 797596
All codes where peanut is not declared on the label
Issue
Korea Food Trading Ltd. is recalling Q One Homemade brand Blackrice & Honey Hoddeok Mix from the marketplace because it contains peanuts which are not declared on the label.
The recalled product has been sold in Ontario and Quebec.
What you should do
Check to see if you have recalled products
If you have an allergy to peanuts, do not consume the recalled product as it may cause a serious or life-threatening reaction
Recalled products should be thrown out or returned to the location where they were purchased
This recall was triggered by a consumer complaint.
There has been one reported reaction associated with the consumption of this product.
What is being done
The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated food recall warnings.
The CFIA is verifying that industry is removing recalled products from the marketplace.
Children's HealthSM and UT Southwestern Medical Center announced a historic gift of $100 million from the Jean and Mack Pogue family in support of the $5 billion new Dallas pediatric campus, unveiled earlier this year. The gift from the Pogue...
Amgen will host a webcasted call for the investment community at 1:00 p.m. PT on Monday, May 20, 2024 following the presentation of new data from TEZSPIRE® in chronic obstructive pulmonary disease (COPD) at the American Thoracic Society (ATS)...
Baltimore Urban Gardening with Students (BUGS), a program operated by The Crossroads School, a Living Classrooms Foundation Charter School, is excited to announce its 26th Annual Youth Farmer's Market taking place on Saturday, May 18th, from 9:00 AM...
DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") , a healthcare technology company focused on brain health using AI, is pleased to announce that it is arranging a private placement of a minimum of $400,000 and a maximum of $650,000 of units...
A new guideline has been issued to help neurologists and other clinicians determine the best antiseizure medications for people with epilepsy who may become pregnant. The guideline is published in the May 15, 2024, online issue of Neurology®, the...